Tuesday, December 3, 2019

Strides Pharma gets tentative nod from USFDA for pain relieving drug

Strides Pharma gets tentative nod from USFDA for pain relieving drug Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2LlNJo7
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...